Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.

Last updated on 3-10-2023 by Marie Malingreau

Public Access


Peer reviewed scientific article



In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. VALGENT is designed to assess the analytical and clinical performance of HPV tests with genotyping capacity. The VALGENT-3 panel comprised 1300 consecutive cervical cell specimens enriched with 300 samples with abnormal cytology obtained from women attending the Slovenian cervical cancer screening programme. The INNO-LiPA allows type-specific detection of 32 HPV types; however, for the clinical accuracy asse…

Associated health topics:

QR code

QR code for this page URL